top of page

Alumni Publications

Our residents get the opportunity to conduct high-quality research projects. Many go on to continue to continue produce practice-changing literature throughout their careers. See below for some examples!

Program:

2022
PGY1

Graduation Year: 

Salam ME, Nguyen CT, Knoebel RW, Pettit NN. Practical Challenges With the Implementation of First-Order Pharmacokinetic Analytic Equations for AUC Monitoring for Vancomycin. Ann Pharmacother. 2022 Dec 1:10600280221139242. doi: 10.1177/10600280221139242. Epub ahead of print. PMID: 36453731.

Program:

2022
PGY1&2 HSPAL

Graduation Year: 

Rhodes JA, Bondi DS, Celmins L, Hope C, Knoebel RW. Quality improvement and reconciliation process for automated dispensing cabinet medication overrides. Am J Health-Syst Pharm. 2022; 79(4):306-13. doi:10.1093/ajhp/zxab406

Program:

2022
PGY1&2 HSPAL

Graduation Year: 

Rhodes JAM, McCarthy BC. Scott AC. Automated dispensing cabinet functionality expansion to reduce controlled substance inventory discrepancies. Hospital Pharm. 2022; 57(4):526-531. doi:10.1177/00185787211061380

Program:

2022
PGY2 Cardiology

Graduation Year: 

Okoroike H, Patel S, Simone P, Lavelle R, Austin Szwak J. Impact of inpatient initiation of sodium-glucose cotransporter-2 inhibitors on prescription rates in patients with heart failure with reduced ejection fraction. Am J Cardiol. 2023;186:150-155.

Program:

2022
PGY2 Specialty

Graduation Year: 

Choi D, Lawando A, Lach MK. Health-system specialty pharmacies do the heavy lifting for hospital electronic medication prior authorizations. Am J Health Syst Pharm. 2022;79(17):1405-1406. doi:10.1093/ajhp/zxac134

Program:

2021
PGY1

Graduation Year: 

Moser K, Knoebel RW, Roth C, Parsad S, Schlei Z. Impact of Electronic Interventions on Guideline Concordant Ordering of Rituximab Infusion Rate. Journal of Oncology Pharmacy Practice. February 2022. doi:10.1177/10781552221080722

Program:

2021
PGY1

Graduation Year: 

Naveed M, Bondi DS, Shah PA. Dexmedetomidine versus fentanyl for neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Pediatr Pharmacol Ther. 2022;27(4):352-357.

Program:

2021
PGY2 Cardiology

Graduation Year: 

Shega A, Patel S, Simone P, Nathan S. First report of subcutaneous hyaluronidase for rapid resolution of forearm and hand hematoma caused by cangrelor IV infiltration and access site bleeding, following transradial approach (TRA) percutaneous coronary intervention (PCI). J Am Coll Cardiol. 2021 May; 77(18): S1, 1867.

Program:

2021
PGY2 Emergency Medicine

Graduation Year: 

Gawedzki P, Celmins L, Fisher D. Pharmacist involvement with antiepileptic therapy for status epilepticus in the emergency department. Am J Emerg Med. 2022;59:129-132.

Program:

2021
PGY2 Emergency Medicine

Graduation Year: 

Gawedzki P, Paloucek F. Additional Considerations for Persistent Hyperinsulinemia. J Med Toxicol. 2021;17(2):233-234.

Program:

2021
PGY2 Pediatrics

Graduation Year: 

Galura G, Said SJ, Shah PA, Hissong AM, Chokshi NK, Fauman KR, Rose R, Bondi DS. Comparison of extracorporeal life support anticoagulation utilizing activated clotting time only to a multimodal approach in pediatric patients. J Pediatr Pharmacol Ther. 2022;27(6):517-523.

Program:

2021
PGY2 Pediatrics

Graduation Year: 

Kleespies MS, Shah PA, Bondi DS. Use of calcitonin for hypercalcemia in a premature neonate with congenital mesoblastic nephroma. J Pediatr Pharmacol Ther. 2022;27(7):682-686.

Program:

2020
PGY1

Graduation Year: 

Nguyen CT, Petrucci K, Daily E, Brown AM, Pettit NN, Pisano J. Investigating the impact of a β-lactam allergy label on preoperative antibiotic prophylaxis administration. Infect Control Hosp Epidemiol. 2021 Jun;42(6):710-714. doi: 10.1017/ice.2020.1271. Epub 2020 Nov 17. PMID: 33198838.

Program:

2020
PGY1

Graduation Year: 

Collins JM, Gawedzki P. Impact of the Implementation of a Pharmacist-Driven Immunosuppression Drug Monitoring Protocol for Hematopoietic Stem Cell Transplant Recipients Biology of Blood and Marrow Transplantation. J Oncol Pharm Practice. 2020. 1-7.

Program:

2020
PGY2 Internal Medicine

Graduation Year: 

Cirbus K, Simone P, Austin Szwak J. Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopenia. J Clin Pharm Ther. 2022 Jan; 47(1): 112-114.

Program:

2020
PGY2 Pediatrics

Graduation Year: 

Wilson GA, Bondi DS, Shah PA, Nelson A, Kumar M, Bhagat P. Neonatal serum gentamicin concentrations and outcomes following maternal once-daily gentamicin dosing. J Pediatr Pharmacol Ther. (Accepted Sep. 2022).

Program:

2019
PGY1

Graduation Year: 

Patel PD, Bhagat P, Bartlett AH, Bondi DS. Comparison of neonatal outcomes with the use cefotaxime versus ceftazidime in a neonatal intensive care unit. J Pediatr Pharmacol Ther. 2020;25(2):117-123.

Program:

2019
PGY2 Cardiology

Graduation Year: 

Gannon M, Simone P. Impact of nurse-driven heparin protocol for ventricular assist devices. AACN Adv Crit Care. 2021 Jun 15; 32(2): 146-151.

Program:

2019
PGY2 Critical Care

Graduation Year: 

Gregorowicz AJ, Costello PG, Gajdosik DA, Purakal J, Pettit NN, Bastow S, Ward MA. Effect of IV Push Antibiotic Administration on Antibiotic Therapy Delays in Sepsis. Crit Care Med. 2020 Aug;48(8):1175-1179. doi: 10.1097/CCM.0000000000004430. PMID: 32697488.

Program:

2019
PGY2 Pediatrics

Graduation Year: 

Pan I, Shah PA, Singh J, Kelly KN, Bondi DS. Comparison of neonatal outcomes with and without prophylaxis with indomethacin in premature neonates. J Pediatr Pharmacol Ther. 2021;26(5):478-483.

Program:

2019
PGY2 Pediatrics

Graduation Year: 

Weaver KL, Bondi DS, Shah PA, Bhagat PH. Evaluation of appropriateness and cost savings of pharmacist-driven palivizumab ordering. J Pediatr Pharmacol Ther. 2020;25(7):636-641.

Program:

2018
PGY1&2 HSPAL

Graduation Year: 

Corsi MP, Shea K, Knoebel RW. Impact of transitioning inpatient chemotherapy regimens to the outpatient setting. J Oncol Pharm Pract. 2020 Sep;26(6):1324-1330. PMID: 31822200.

Program:

2018
PGY2 Hematology/Oncology

Graduation Year: 

Collins JM, Serbas L, Parsad S. Considerations for Initiation of Lu-Dotatate therapy at a large academic medical center. Oncolytics Today. 2021. 35-39.

Program:

2018
PGY2 Hematology/Oncology

Graduation Year: 

Collins JM et al. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation. J Oncol Pharm Practice. 2019.

Program:

2018
PGY2 Infectious Diseases

Graduation Year: 

Ridgway JP, Friedman EE, Choe J, Nguyen CT, Schuble T, Pettit NN. Impact of mail order pharmacy use and travel time to pharmacy on viral suppression among people living with HIV. AIDS Care. 2020 Nov;32(11):1372-1378. doi: 10.1080/09540121.2020.1757019. Epub 2020 May 4. PMID: 32362129; PMCID: PMC7572477.

Program:

2018
PGY2 Internal Medicine

Graduation Year: 

Froomkin J, Knoebel RW, Dickerson D, Soni H, Szwak J. Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive Crisis. Hospital Pharmacy. March 2021. doi:10.1177/0018578721999806

Program:

2017
PGY1

Graduation Year: 

Collins JM, Dennis EE, Green MW, and Greene EM. Patient self-prescription and antimicrobial stewardship: considerations for primary care. J APhA. 2020. 1-4.

Program:

2017
PGY1

Graduation Year: 

Collins JM, Fleming GF, and Christ TN. Comparison of the incidence of febrile neutropenia in obese and and normal weight breast cancer patients receiving myelosuppressive chemotherapy and prophylactic pegfilgrastim. J Oncol Pharm Practice. 2018.

Program:

2017
PGY2 Hematology/Oncology

Graduation Year: 

Plach K, Knoebel RW, Nanda R, Shea K. Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center. J Oncol Pharm Pract. 2017 Jan 1. PMID: 29020855.

Program:

2016
PGY2 Critical Care

Graduation Year: 

Dunker A, Kolanczyk DM, Maendel CM, Patel AR, Pettit NN. Impact of the FDA Warning for Azithromycin and Risk for QT Prolongation on Utilization at an Academic Medical Center. Hosp Pharm. 2016 Nov;51(10):830-833. doi: 10.1310/hpj5110-830. PMID: 27928188; PMCID: PMC5135431.

Program:

2016
PGY2 Critical Care

Graduation Year: 

Shumaker AC, Bullard HM, Churpek J, Knoebel RW. Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein. J Oncol Pharm Pract. 2019 Oct;25(7):1758-1761. PMID: 30259783.

Program:

2016
PGY2 Hematology/Oncology

Graduation Year: 

Lee P, Knoebel RW, Pisano J, Pettit NN. Moxifloxacin versus levofloxacin for antibacterial prophylaxis in acute leukemia patients. J Oncol Pharm Pract. 2019 Apr;25(3):758-761. PMID: 29310512.

Program:

2016
PGY2 Pediatrics

Graduation Year: 

Shenk EE, Bondi DS, Pellerite MM, Sriram S. Evaluation of timing and dosing of caffeine citrate in preterm neonates for the prevention of bronchopulmonary dysplasia. J Pediatr Pharmacol Ther. 2018;23(2): 139-145.

Program:

2015
PGY2 Cardiology

Graduation Year: 

Minner SA, Simone P, Chung BB, Shah AS. Successful reversal of bradycardia and dyspnea with aminophylline after ticagrelor load. J Pharm Pract. 2018 Feb; 31(1): 112-114.

Program:

2015
PGY2 Internal Medicine

Graduation Year: 

Buehrle K, Pisano J, Han Z, Pettit NN. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review. Am J Infect Control. 2017 Jul 1;45(7):713-716. doi: 10.1016/j.ajic.2017.02.030. Epub 2017 Apr 18. PMID: 28431847.

Program:

2015
PGY2 Pediatrics

Graduation Year: 

Welsh KM, Bondi DS, Frost B. Probiotics for prevention of necrotizing enterocolitis in preterm neonates. NeoReviews. 2016;17(7):e377-e385.

Program:

2014
PGY1

Graduation Year: 

Christ TN, Villadolid JJ, Choksi A, Malec M, Knoebel RW. Impact of a Clinical Decision Support Tool on Cancer Pain Management in Opioid-Tolerant Inpatients. Hosp Pharm. 2018 Jul;53(4):256-262. PMID: 30038445

Program:

2014
PGY2 Hematology/Oncology

Graduation Year: 

Christ TN, Stock W, Knoebel RW. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen. J Oncol Pharm Pract. 2018 Jun;24(4):299-308. PMID: 28355969.

Program:

2014
PGY2 Hematology/Oncology

Graduation Year: 

Derman BA, Streck M, Wynne J, Christ TN, Curran E, Stock W, Knoebel RW. Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Leuk Lymphoma. 2020 Mar;61(3):614-622. PMID: 31680584

Program:

2013
PGY2 Infectious Diseases

Graduation Year: 

Han Z, Pettit NN, Landon EM, Brielmaier BD. Impact of Pharmacy Practice Model Expansion on Pharmacokinetic Services: Optimization of Vancomycin Dosing and Improved Patient Safety. Hosp Pharm. 2017 Apr;52(4):273-279. doi: 10.1310/hpj5204-273. PMID: 28515506; PMCID: PMC5424831.

Program:

2012
PGY1

Graduation Year: 

Mearis M, Shega JW, Knoebel RW. Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center. J Pain Symptom Manage. 2014 Sep;48(3):451-8. PMID: 24439844.

Program:

2012
PGY2 Hematology/Oncology

Graduation Year: 

Vicente M, Al-Nahedh M, Parsad S, Knoebel RW, Pisano J, Pettit NN. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia. J Oncol Pharm Pract. 2017 Dec;23(8):575-581. doi: 10.1177/1078155216668672. Epub 2016 Sep 8. PMID: 27609336.

Program:

2012
PGY2 Hematology/Oncology

Graduation Year: 

Kang Y, Vicente M, Parsad S, Brielmeier B, Pisano J, Landon E, Pettit NN. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients. Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4. PMID: 23911080.

Program:

2012
PGY2 Pediatrics

Graduation Year: 

Povine AD, Simmons EM, Bhagat PH. Establishment and evaluation of pharmacist-managed admission medication history and reconciliation process for pediatric patients. J Pediatric Pharmacol Ther. 2014;19(2):98-102.

bottom of page